Swiss National Bank
RVMD icon

Swiss National Bank’s Revolution Medicines RVMD Stock Holding History

Swiss National Bank’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.5M Buy
456,331
+30,900
+7% +$4.51M 0.04% 316
2026
Q1 		$41.4M Buy
425,431
+149,100
+54% +$15.1M 0.02% 490
2025
Q4 		$22M Buy
276,331
+5,500
+2% +$361K 0.01% 625
2025
Q3 		$12.6M Buy
270,831
+4,400
+2% +$172K 0.01% 836
2025
Q2 		$9.8M Sell
266,431
-10,100
-4% -$388K 0.01% 929
2025
Q1 		$9.78M Buy
276,531
+46,600
+20% +$1.89M 0.01% 912
2024
Q4 		$10.1M Buy
229,931
+4,400
+2% +$222K 0.01% 945
2024
Q3 		$10.2M Sell
225,531
-1,300
-0.6% -$56.6K 0.01% 925
2024
Q2 		$8.8M Buy
226,831
+26,700
+13% +$998K 0.01% 961
2024
Q1 		$6.45M Hold
200,131
– – ﹤0.01% 1135
2023
Q4 		$5.74M Buy
200,131
+36,531
+22% +$878K ﹤0.01% 1208
2023
Q3 		$4.53M Buy
163,600
+1,800
+1% +$53.4K ﹤0.01% 1334
2023
Q2 		$4.33M Sell
161,800
-6,800
-4% -$167K ﹤0.01% 1397
2023
Q1 		$3.65M Buy
168,600
+20,300
+14% +$500K ﹤0.01% 1453
2022
Q4 		$3.53M Buy
148,300
+6,000
+4% +$128K ﹤0.01% 1527
2022
Q3 		$2.81M Buy
142,300
+38,100
+37% +$837K ﹤0.01% 1641
2022
Q2 		$2.03M Sell
104,200
-9,000
-8% -$175K ﹤0.01% 1906
2022
Q1 		$2.89M Buy
113,200
+7,700
+7% +$168K ﹤0.01% 1809
2021
Q4 		$2.65M Hold
105,500
– – ﹤0.01% 1873
2021
Q3 		$2.9M Buy
105,500
+2,100
+2% +$61.1K ﹤0.01% 1808
2021
Q2 		$3.28M Buy
103,400
+57,900
+127% +$2.02M ﹤0.01% 1780
2021
Q1 		$2.09M Buy
45,500
+800
+2% +$35.9K ﹤0.01% 1976
2020
Q4 		$1.77M Buy
44,700
+8,500
+23% +$336K ﹤0.01% 1972
2020
Q3 		$1.26M Buy
36,200
+9,900
+38% +$274K ﹤0.01% 1960
2020
Q2 		$830K Buy
+26,300
New +$827K ﹤0.01% 2206

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Swiss National Bank's RVMD Position: Q2 2026 in Review

Swiss National Bank increased its Revolution Medicines (RVMD) stake by 7.3% in Q2 2026, buying an estimated $4.51M and bringing the position to 456,331 shares worth $85.5M. The position accounts for 0.04% of the portfolio, ranked #316.

Swiss National Bank first reported a position in RVMD in Q2 2020 and has held it in 25 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Swiss National Bank held 456,331 shares of Revolution Medicines worth $85.5M as of Q2 2026.
  • Swiss National Bank bought 30,900 Revolution Medicines shares in Q2 2026, an estimated $4.51M.
  • Revolution Medicines made up 0.04% of Swiss National Bank's portfolio in Q2 2026, its #316 holding.
  • Swiss National Bank first reported a position in Revolution Medicines in Q2 2020 and has held it in 25 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.